Pharvaris N.V.
PHVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001830487
In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 18 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.
Q1 2023 vs. Q4 2022
How the institutions holding Pharvaris N.V. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 25 | 21 | −4 |
| Shares | 21.3M | 21.8M | +479.6K (+2.3%) |
| Value | $239.6M | $173.9M | −$65.8M (−27.4%) |
New holders (0)
Institutions that held Pharvaris N.V. at the end of Q1 2023 but not at the end of Q4 2022.
None.
Sold out (4)
Institutions that held Pharvaris N.V. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Tower Research Capital LLC (TRC) | 12,993 | $146.0K |
| Quantamental Technologies LLC | 12,900 | $145.1K |
| Millennium Management LLC | 10,286 | $116.0K |
| FNY Investment Advisers, LLC | 880 | $9.00K |